DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Ottawa Marriott Hotel

2013年10月29日 (火) 午前 8:30 - 2013年10月30日 (水) 午後 3:00

100 Kent Street , Ottawa, ON K1P5R7 , CANADA

DIA's Annual Canadian Meeting: New Reality / New Frontiers

Session 3 Tract 2 - Communications: Social Media

Session Chair(s)

Deirdre  Cozier

Deirdre Cozier

Director, Global Regulatory Affairs

Pharmascience, Canada

The increasing popularity of social media networks is changing consumer behavior. An entire generation now communicates via tweets, pins and IMs. Consumer endorsement has a powerful, and near instantaneous, effect on company strategy. This has required the business community to adapt to this technology and engage their customers in more personal and virtual ways. In an industry as tightly regulated as pharmaceuticals, the use of social media platforms to engage, inform and promote raises some unique challenges. This session will explore the uses of social media both from an industry and regulator perspective. From R&D, to internal collaboration and compliance considerations, the three speakers will share best practices and provide valuable tips to ensure that your use of social media platforms is successful.

Speaker(s)

Susant  Mallick, MBA

Harnessing Power of SMAC (Social Media, Mobility, Analytics & Cloud) to Drive Transformation in Clinical R&D

Susant Mallick, MBA

Cloudhub BV, Netherlands

Founder and CEO, Life Sciences Practice Leader

Brenda M Gryfe, MPharm

Social Media as Health Communication Tools in Canada

Brenda M Gryfe, MPharm

OptumInsight (Canada) Inc., Canada

Director, Canadian Regulatory Affairs

Alain G. Musende, PhD

Regulatory Considerations of Using Social Media

Alain G. Musende, PhD

Marketed Health Products Directorate, Health Canada, Canada

Manager, Section for Transparency and Advertising Regulatory Surveillance

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。